Curasan expands in Europe, sets sights on US and Japan
This article was originally published in Clinica
German company Curasan, a specialist in regenerative biomedicine, has signed an agreement with Kensey Nash to distribute the US company's Epi-Guide periodontal barrier matrix in Europe and the Middle East. "Curasan has a well established distribution infrastructure throughout Europe and the Middle East," said Joe Kaufmann, president and CEO of Kensey Nash, adding that the its product offerings were highly complementary to Epi-Guide. Epi-Guide, which has recently been CE-marked and is on sale in the US, is a resorbable membrane intended for use in periodontal restorative surgeries for improving tissue regeneration in the healing of periodontal defects.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.